These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 12242903)

  • 21. Quality-of-life outcomes for men with prostate carcinoma detected by screening.
    Smith DS; Carvalhal GF; Schneider K; Krygiel J; Yan Y; Catalona WJ
    Cancer; 2000 Mar; 88(6):1454-63. PubMed ID: 10717630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experiences of symptoms in men with hormone refractory prostate cancer and skeletal metastases.
    Lindqvist O; Rasmussen BH; Widmark A
    Eur J Oncol Nurs; 2008 Sep; 12(4):283-90. PubMed ID: 18440862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality of life and emotional distress in advanced prostate cancer survivors undergoing chemotherapy.
    Trask PC
    Health Qual Life Outcomes; 2004 Jul; 2():37. PubMed ID: 15272941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient-reported acute gastrointestinal toxicity in men receiving 3-dimensional conformal radiation therapy for prostate cancer with or without neoadjuvant androgen suppression therapy.
    Tsai HK; Manola J; Abner A; Talcott JA; D'Amico AV; Beard C
    Urol Oncol; 2005; 23(4):230-7. PubMed ID: 16018937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regret in men treated for localized prostate cancer.
    Hu JC; Kwan L; Saigal CS; Litwin MS
    J Urol; 2003 Jun; 169(6):2279-83. PubMed ID: 12771770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in health-related quality of life of prostate cancer patients based on stage of cancer.
    Rosenfeld B; Roth AJ; Gandhi S; Penson D
    Psychooncology; 2004 Nov; 13(11):800-7. PubMed ID: 15386638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of life after therapy for localized prostate cancer.
    Penson DF
    Cancer J; 2007; 13(5):318-26. PubMed ID: 17921731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy for older patients with prostate cancer.
    Anderson J; Van Poppel H; Bellmunt J; Miller K; Droz JP; Fitzpatrick JM
    BJU Int; 2007 Feb; 99(2):269-73. PubMed ID: 16981902
    [No Abstract]   [Full Text] [Related]  

  • 29. Pain management at home. Struggle, comfort, and mission.
    Ferrell BR; Taylor EJ; Grant M; Fowler M; Corbisiero RM
    Cancer Nurs; 1993 Jun; 16(3):169-78. PubMed ID: 8348524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing the attitudes to prostate cancer treatment among European male patients.
    Schulman C
    BJU Int; 2007 Jul; 100 Suppl 1():6-11. PubMed ID: 17593202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patients' perceptions of quality of life after treatment for early prostate cancer.
    Clark JA; Inui TS; Silliman RA; Bokhour BG; Krasnow SH; Robinson RA; Spaulding M; Talcott JA
    J Clin Oncol; 2003 Oct; 21(20):3777-84. PubMed ID: 14551296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coping and health-related quality of life in men with prostate cancer randomly assigned to hormonal medication or close monitoring.
    Green HJ; Pakenham KI; Headley BC; Gardiner RA
    Psychooncology; 2002; 11(5):401-14. PubMed ID: 12228873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contemporary use of hormonal therapy in prostate cancer: managing complications and addressing quality-of-life issues.
    Gomella LG
    BJU Int; 2007 Jan; 99 Suppl 1():25-9; discussion 30. PubMed ID: 17229166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with nonmetastatic prostate cancer.
    Joly F; Alibhai SM; Galica J; Park A; Yi QL; Wagner L; Tannock IF
    J Urol; 2006 Dec; 176(6 Pt 1):2443-7. PubMed ID: 17085125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of quality of life and subjective response criteria in patients with prostatic cancer.
    Fosså SD; Aaronson N; de Voogt HJ; da Silva FC
    Prog Clin Biol Res; 1990; 357():199-202. PubMed ID: 2217464
    [No Abstract]   [Full Text] [Related]  

  • 36. Prostate cancer: perspectives on quality of life and impact of treatment on patients and their partners.
    Crowe H; Costello AJ
    Urol Nurs; 2003 Aug; 23(4):279-85. PubMed ID: 14552074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Counterpoint: Men should be treated for hormone refractory prostate cancer with systemic chemotherapy when they are symptomatic, and not before.
    Moore MJ
    Can J Urol; 2003 Dec; 10(6):2038-9. PubMed ID: 14704107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The experiences of men receiving androgen deprivation treatment for prostate cancer: a qualitative study.
    Gray RE; Wassersug RJ; Sinding C; Barbara AM; Trosztmer C; Fleshner N
    Can J Urol; 2005 Aug; 12(4):2755-63. PubMed ID: 16197599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer-related pain and quality of life in prostate cancer patients: assessment using the Functional Assessment of Prostate Cancer Therapy.
    Fujimura T; Takahashi S; Kume H; Takeuchi T; ; Kitamura T; Homma Y
    Int J Urol; 2009 May; 16(5):522-5. PubMed ID: 19383037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spirituality influences health related quality of life in men with prostate cancer.
    Krupski TL; Kwan L; Fink A; Sonn GA; Maliski S; Litwin MS
    Psychooncology; 2006 Feb; 15(2):121-31. PubMed ID: 15880458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.